透导管与手术肺置换的比较影响:系统性审查和元分析

Bunchai Chongmelaxme1,2, Kok Pim Kua2,3,4,5,6,7, Chanokpol Amornvetchayakul1

  • 1Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.

PloS one
|May 20, 2025
PubMed
概括

透气管肺置换 (TPVR) 改善了患者的生存率,但与手术肺置换 (SPVR) 相比,增加了感染性内心炎的风险. 这种微创手术需要仔细考虑其益处和风险.